Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 481.00
Bid: 480.00
Ask: 484.50
Change: -4.00 (-0.82%)
Spread: 4.50 (0.938%)
Open: 480.00
High: 489.50
Low: 480.00
Prev. Close: 485.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

7 Apr 2020 07:00

RNS Number : 9761I
Treatt PLC
07 April 2020
 

 

 

7 April 2020

 

TREATT PLC

("Treatt" or "the Group")

 

Trading update for the half year ended 31 March 2020

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the beverage, flavour, fragrance and consumer product industries today publishes a trading update for the half year ended 31 March 2020 (the "Period").

 

Treatt plays a critical role in the food, beverage and cleaning supply chains and order intake in recent weeks has been strong as a number of our customers respond to increased demand for beverages consumed at home and cleaning products (such as liquid hand soaps and floor cleaning products) which are of particular importance at this time.

 

As such, the Board can confirm that, to date, there has not been any adverse effect on the trading performance of the Group due to COVID-19 and the Group is currently trading in line with the Board's expectations.

 

The business has taken, and will continue to take, timely action to protect the health and safety of all its employees across the Group as well as doing all it can to support the communities in which it operates. We received early indications of the likely steps that would follow from our colleagues in Shanghai, where our office remained open, albeit operating for one month on a staff rota, and whom we are pleased to say have now all returned to work. In both the UK and US all non-essential staff are working from home and manufacturing continues, working within government guidelines and with appropriate health protection and wellbeing measures in place.

 

As previously reported, we expected the sharp fall in citrus raw material prices in the last financial year to continue to impact upon revenue in the first half of the current financial year. Consequently, whilst in-line with expectations, revenue for the Period is expected to be approximately 5.1% lower as compared with the same period in the prior year (5.6% lower in constant currency).

 

Whilst citrus remains a significant part of the Group's business, there was good growth in reported revenue from fruit and vegetables (up 9.4%), tea (up 47.5%) and health and wellness (incl. sugar reduction) (up 19.9%). The vast majority of Treatt's portfolio is targeted at the growing demand from consumers for more natural and clean-label products which is helping to drive our financial performance as well as our encouraging opportunity pipeline. Our customers continue to look to product innovation to differentiate their products, launch new products and categories and refresh existing products. Treatt continues to benefit from the valuable role our services play in helping meet these demands with the Group's new product development programme progressing well with market entry points currently being explored.

 

Building work on our new facility in the UK has inevitably slowed as a consequence of the COVID-19 pandemic. We now expect that our UK relocation may not take place until 2021 but at this stage it is not possible to confirm a new definitive timescale. The delay to our UK relocation will not affect our ability to meet customer orders in the short to medium term but such a delay does enable the Group to preserve cash during this period of uncertainty. At the end of the Period the Group had net cash of £6.5m and total bank facilities of £25.0m, of which £24.9m remains undrawn.

 

As previously reported, the expansion of our US manufacturing facility was completed last year and is now fully operational. Our capacity for products in our fast-growing fruit and vegetables, health and wellness and tea product categories has now doubled and is coming on stream in time for the new crop season as growth in these categories continues from both new and existing customers.

 

The Group has a hedging strategy in place to try to minimise the impact of exchange rate movements over the course of a financial year though there can be material effects over shorter periods of time. During the Period there was a strengthening in the USD/GBP exchange rate and, as a result, the Board anticipates a net positive FX impact on the results for the Period of approximately £0.6m.

 

Outlook

The focus we have made over recent years on the culture in the business means that we have an incredibly strong and committed team of employees who we know will shine in these exceptional times, whilst protecting the health and safety of each other and the wider communities in which we operate.

 

The business is both trading well and is financially robust; we are encouraged by our order book and current demand as we move into our peak seasonal period. Also, and as expected, citrus raw material prices are firming once more, which should result in a stronger performance from our citrus category in the second half of the financial year. Whilst it is difficult to determine the likely impact of COVID-19 on the demand for the Group's products in the coming months, our early experience has shown demand to be robust and at this time, trading remains in line with the Board's expectations.

 

It is currently expected that Treatt's half year results for the six months ended 31 March 2020 will be announced on 12 May 2020.

 

Enquiries:

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3951 0349

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFITSVIRIII
Date   Source Headline
27th Jun 201111:11 amRNSDirector/PDMR Shareholding
27th Jun 201111:02 amRNSDirector/PDMR Shareholding
23rd Jun 201110:34 amRNSDirector/PDMR Shareholding
23rd May 20117:00 amRNSHalf Yearly Report
20th May 20113:56 pmRNSDirectorate Change
31st Mar 201110:30 amRNSHolding(s) in Company
30th Mar 20112:14 pmRNSDirector/PDMR Shareholding
24th Mar 201111:47 amRNSHolding(s) in Company
22nd Mar 20117:00 amRNSPre close trading update
4th Mar 20114:23 pmRNSDirector/PDMR Shareholding
28th Feb 201111:23 amRNSVoting Rights & Capital
25th Feb 20113:05 pmRNSResult of AGM
15th Feb 20117:00 amRNSInterim Management Statement
31st Jan 201110:27 amRNSVoting Rights & Capital
6th Jan 201111:54 amRNSHolding(s) in Company
31st Dec 20107:00 amRNSAnnual Information Update
31st Dec 20107:00 amRNSTotal Voting Rights
17th Dec 20102:44 pmRNSAnnual Financial Report
6th Dec 20107:00 amRNSPreliminary Results
29th Oct 20107:00 amRNSTotal Voting Rights
21st Oct 201010:00 amRNSDirector/PDMR Shareholding
21st Oct 201010:00 amRNSDirector/PDMR Shareholding
21st Oct 201010:00 amRNSDirector/PDMR Shareholding
21st Oct 201010:00 amRNSDirector/PDMR Shareholding
30th Sep 201011:12 amRNSTotal Voting Rights
1st Sep 20104:57 pmRNSDirector/PDMR Shareholding
1st Sep 20104:56 pmRNSDirector/PDMR Shareholding
1st Sep 20104:52 pmRNSDirector/PDMR Shareholding
31st Aug 20104:11 pmRNSTotal Voting Rights
6th Aug 20102:32 pmRNSInterim Management Statement
30th Jul 20109:19 amRNSTotal Voting Rights
29th Jul 20104:46 pmRNSDirector/PDMR Shareholding
29th Jul 20104:42 pmRNSDirector/PDMR Shareholding
29th Jul 20104:34 pmRNSDirector/PDMR Shareholding
30th Jun 20107:00 amRNSTotal Voting Rights
29th Jun 20105:04 pmRNSHolding(s) in Company
24th May 20107:00 amRNSHalf Yearly Report
30th Apr 201012:00 pmRNSTotal Voting Rights
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
26th Feb 201011:06 amRNSTotal Voting Rights
19th Feb 20103:15 pmRNSResults of AGM and Board Change
12th Feb 20101:57 pmRNSInterim Management Statement
31st Dec 20097:00 amRNSAnnual Information Update
31st Dec 20097:00 amRNSDirectorate Change
18th Dec 200911:23 amRNSAnnual Financial Report
9th Dec 200910:46 amRNSDirector Declaration
7th Dec 20097:00 amRNSFinal Results
4th Dec 20094:02 pmRNSBoard Appointment
24th Nov 200910:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.